These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27685901)

  • 1. The role and the potential regulatory pathways of high expression of forkhead box C1 in promoting tumor growth and metastasis of basal-like breast cancer.
    Zuo HD; Wu Yao W
    J BUON; 2016; 21(4):818-825. PubMed ID: 27685901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential pathway of FOXC1 high expression in regulating the proliferation, migration, cell cycle and epithelialmesenchymal transition of basal-like breast cancer and in vivo imaging.
    Zuo H; Yang Q
    J BUON; 2018; 23(3):720-728. PubMed ID: 30003742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.
    Du J; Li L; Ou Z; Kong C; Zhang Y; Dong Z; Zhu S; Jiang H; Shao Z; Huang B; Lu J
    Breast Cancer Res Treat; 2012 Jan; 131(1):65-73. PubMed ID: 21465172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.
    Jin Y; Han B; Chen J; Wiedemeyer R; Orsulic S; Bose S; Zhang X; Karlan BY; Giuliano AE; Cui Y; Cui X
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4(0 4):S758-66. PubMed ID: 25124473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
    Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
    J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer.
    Chung S; Jin Y; Han B; Qu Y; Gao B; Giuliano AE; Cui X
    Cell Commun Signal; 2017 Jun; 15(1):22. PubMed ID: 28629477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
    Tan M; Yao J; Yu D
    Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forkhead box C1 boosts triple-negative breast cancer metastasis through activating the transcription of chemokine receptor-4.
    Pan H; Peng Z; Lin J; Ren X; Zhang G; Cui Y
    Cancer Sci; 2018 Dec; 109(12):3794-3804. PubMed ID: 30290049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal regulation of forkhead box C1 and L1 cell adhesion molecule contributes to triple-negative breast cancer progression.
    Zhang F; Xu Y; Lin J; Pan H; Giuliano AE; Cui X; Cui Y
    Breast Cancer Res Treat; 2024 Apr; 204(3):465-474. PubMed ID: 38183514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
    Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
    Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth inhibitor affects the invasion, apoptosis and vascularisation in breast cancer cell line MDA-MB-231.
    Gao Y; Ge Z; Zhang Z; Bai Z; Ma X; Wang Y
    Chin Med J (Engl); 2014; 127(10):1947-53. PubMed ID: 24824261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forkhead box C1 promoter upstream transcript, a novel long non-coding RNA, regulates proliferation and migration in basal-like breast cancer.
    Liu J; Shen L; Yao J; Li Y; Wang Y; Chen H; Geng P
    Mol Med Rep; 2015 Apr; 11(4):3155-9. PubMed ID: 25516208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXC1 Regulates FGFR1 Isoform Switching to Promote Invasion Following TGFβ-Induced EMT.
    Hopkins A; Coatham ML; Berry FB
    Mol Cancer Res; 2017 Oct; 15(10):1341-1353. PubMed ID: 28684636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort.
    Johnson J; Choi M; Dadmanesh F; Han B; Qu Y; Yu-Rice Y; Zhang X; Bagaria S; Taylor C; Giuliano AE; Amersi F; Cui X
    Oncotarget; 2016 Nov; 7(46):75729-75738. PubMed ID: 27708239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CircIRAK3 sponges miR-3607 to facilitate breast cancer metastasis.
    Wu J; Jiang Z; Chen C; Hu Q; Fu Z; Chen J; Wang Z; Wang Q; Li A; Marks JR; Guo C; Chen Y; Zhou J; Yang L; Lin C; Wang S
    Cancer Lett; 2018 Aug; 430():179-192. PubMed ID: 29803789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a bioluminescent MDA-MB-231 cell line for human triple-negative breast cancer research.
    Wang K; Xie S; Ren Y; Xia H; Zhang X; He J
    Oncol Rep; 2012 Jun; 27(6):1981-9. PubMed ID: 22446691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay.
    Jensen TW; Ray T; Wang J; Li X; Naritoku WY; Han B; Bellafiore F; Bagaria SP; Qu A; Cui X; Taylor CR; Ray PS
    J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26041837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Hypoxia Regulates Forkhead Box C1 to Promote Lung Cancer Progression.
    Lin YJ; Shyu WC; Chang CW; Wang CC; Wu CP; Lee HT; Chen LJ; Hsieh CH
    Theranostics; 2017; 7(5):1177-1191. PubMed ID: 28435457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXC1: an emerging marker and therapeutic target for cancer.
    Han B; Bhowmick N; Qu Y; Chung S; Giuliano AE; Cui X
    Oncogene; 2017 Jul; 36(28):3957-3963. PubMed ID: 28288141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of FOXC1 as a therapeutic target for basal-like breast cancer.
    Mott L; Su K; Pack DW
    Cancer Gene Ther; 2018 May; 25(3-4):84-91. PubMed ID: 29511313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.